½ÃÀ庸°í¼­
»óǰÄÚµå
1350250

¼¼°èÀÇ ¾î·¹ÀÌ(»ý¸í°úÇÐ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ±â±â) ½ÃÀå : À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° - ½ÃÀå ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2023-2030³â)

Array Market (Life Science and Biotechnology Instruments), By Type, By End User, And By Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¾î·¹ÀÌ(»ý¸í°úÇÐ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ±â±â) ½ÃÀåÀº 2023³â¿¡ 74¾ï ´Þ·¯·Î ÃßÁ¤¡¤¿¹ÃøµÇ¾úÀ¸¸ç, ¿¹Ãø ±â°£ Áß(2023-2030³â)ÀÇ CAGRÀº 15.4%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

º¸°í¼­ ´ë»ó ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁس⵵ 2022³â 2023³â ½ÃÀå ±Ô¸ð 74¾ï ´Þ·¯
°ú°Å µ¥ÀÌÅÍ 2018-2021³â ¿¹Ãø ±â°£ 2023-2030³â
¿¹Ãø ±â°£(2023-2030³â)ÀÇ CAGR : 15.40% 2030³â °¡Ä¡ ¿¹Ãø 201¾ï 5,000¸¸ ´Þ·¯
Array Market-IMG1

DNA ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ¶Ç´Â ĨÀº ´Ù¾çÇÑ À¯ÀüÀÚÀÇ ¼­¿­ÀÌ ÇÁ·Îºê¿¡ °áÇÕµÈ ¹ÝµµÃ¼ Ç¥¸éÀÔ´Ï´Ù. DNA ¸¶ÀÌÅ©·Î¾î·¹ÀÌ´Â °Ô³ðÀÇ ¿©·¯ ¿µ¿ªÀ» À¯ÀüÇü ºÐ¼®Çϰųª ¿©·¯ À¯ÀüÀÚÀÇ ¹ßÇö ¼öÁØÀ» ÇÑ ¹ø¿¡ Æò°¡ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÀÌ ¹æ¹ýÀº ÀÓ»ó Áø´Ü, ³ó¾÷, ȯ°æ °ü¸® ¹× ±âŸ ºÐ¾ß¿¡ Àû¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ¶Ç´Â ¹ÙÀÌ¿ÀĨÀº ÀϹÝÀûÀ¸·Î À¯¸®, ½Ç¸®ÄÜ Ä¨ ¶Ç´Â ³ªÀÏ·Ð ¸âºê·¹ÀÎÀ¸·Î ¸¸µé¾îÁø ½ÇÇè½Ç¿ë Çö¹Ì°æ ½½¶óÀ̵åÀÔ´Ï´Ù. Ç¥¸éÀÌ Á¤ÀÇµÈ À§Ä¡¿¡ ¼öõ °³ÀÇ ¹Ì¼¼ÇÑ ±â°øÀÌ ÀÖ´Â 2D ¾î·¹ÀÌ(¶§·Î´Â 3D)ÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ

¸¶ÀÌÅ©·Î¾î·¹ÀÌ´Â »ý¹°ÇÐÀû Á¤º¸¿Í »ý¹°Á¤º¸ÇÐ Áö½ÄÀ» Ȱ¿ëÇÏ¿© ¸¹Àº »ý¹°ÇÐÀû ½Ã½ºÅÛ¿¡ »õ·Î¿î ÅëÂû·ÂÀ» Á¦°øÇϸç, ¾Ï ¿¬±¸ ºÐ¾ß¿¡ °¡Àå ÁýÁßÀûÀ¸·Î Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. µû¶ó¼­ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ´Â »ùÇÃÀÇ mRNA Àü»çü ¼öÁØÀ» ÃøÁ¤Çϸç, ¼öõ °³ÀÇ À¯ÀüÀÚ Á¶°¢ÀÌ ¾î·¹ÀÌ¿¡ À§Ä¡ÇÒ ¼ö Àֱ⠶§¹®¿¡ ¾ÏÀÇ À¯ÀüÀÚ ¹ßÇö¿¡ ´ëÇÑ °Ô³ð Àü¹ÝÀÇ °üÁ¡À» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ¾Ï À¯º´·ü Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁø ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 2¿ù, Àü ¼¼°è ¾Ï ¹ß»ý·ü ¹× »ç¸Á·ü µ¥ÀÌÅͺ£À̽ºÀÎ ±Û·Îº¸Ä­ÀÌ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é 2020³â¿¡ Àü ¼¼°èÀûÀ¸·Î 1,930¸¸ °ÇÀÇ »õ·Î¿î ¾Ï »ç·Ê°¡ º¸°íµÇ¾ú½À´Ï´Ù. ¿©¼º À¯¹æ¾ÏÀº Æó¾ÏÀ» Á¦Ä¡°í °¡Àå ÈçÇÏ°Ô Áø´ÜµÇ´Â ¾ÏÀÌ µÇ¾úÀ¸¸ç, 2020³â¿¡ Àü ¼¼°èÀûÀ¸·Î ¾à 230¸¸ °ÇÀÇ »õ·Î¿î »ç·Ê°¡ ¹ß»ýÇß°í Æó¾Ï, ´ëÀå¾Ï, Àü¸³¼±¾Ï, À§¾ÏÀÌ ±× µÚ¸¦ À̾ú½À´Ï´Ù.

¶ÇÇÑ, ¹Ì±¹ Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ¿¡ µû¸£¸é 2020³â ¹Ì±¹¿¡¼­´Â 160¸¸ 3,844°ÇÀÇ »õ·Î¿î ¾ÏÀÌ ¹ß»ýÇßÀ¸¸ç 60¸¸ 2,347¸íÀÌ ¾ÏÀ¸·Î »ç¸ÁÇß½À´Ï´Ù.

ÁÖ¿ä Æ¯Â¡

  • ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ¼¼°è ¾î·¹ÀÌ(»ý¸í °úÇÐ ¹× »ý¸í°øÇÐ Àåºñ)¸¦ »ó¼¼ÇÏ°Ô ºÐ¼®Çϰí, 2022³â ±âÁØÀ¸·Î ¿¹Ãø ±â°£(2023-2030³â) µ¿¾È ½ÃÀå ±Ô¸ð ¹× ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR) Çϰí ÀÖ½À´Ï´Ù.
  • ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¸ÅÃâ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø ¿äÀÎ, ¾ïÁ¦ ¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã¿Í ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ¼¼°èÀÇ ¾î·¹ÀÌ(»ý¸í°úÇÐ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ±â±â)ÀÇ ÁÖ¿ä ±â¾÷À» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ¼º°ú, À繫 ½ÇÀû, Àü·« µî ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷À¸·Î´Â Thermo Fisher Scientific Inc., Illumina, Inc., Roche Diagnostics Nederland BV, Bio-Rad Laboratories, Inc., Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., Twist Bioscience Corporation, Arraylt Corporation, Molecular Device, LLC and Raybiotech Inc.¸¦ Æ÷ÇÔÇÕ´Ï´Ù.
  • ÅëÂûÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°èÀÇ ¾î·¹ÀÌ(»ý¸í°úÇÐ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ±â±â) ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, ÆÇ¸ÅÀÚ, ½Å±Ô Âü°¡ÀÚ, ±ÝÀ¶ ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°èÀÇ ¾î·¹ÀÌ(»ý¸í°úÇÐ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ±â±â) ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû ¹× ÀüÁ¦ Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦ Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå ¹üÀ§

  • º¸°í¼­ °³¿ä
    • ½ÃÀå Á¤ÀÇ ¹× ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø ¿äÀÎ
    • ¾ïÁ¦ ¿äÀÎ
    • ½ÃÀå ±âȸ
  • ¿µÇ⠺м®
  • ÇÕº´, Àμö, Á¦ÈÞ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÁÖ¿ä ¹ßÀü
  • PEST ºÐ¼®
  • ±â¼úÀû Áøº¸
  • Á¦Á¶¾÷üÀÇ ¸ÅÃâ

Á¦4Àå ¼¼°èÀÇ ¾î·¹ÀÌ(»ý¸í°úÇÐ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ±â±â) ½ÃÀå-COVID-19 ¿µÇ⠺м®

  • °æÁ¦Àû ¿µÇâ
  • COVID-19 ¿ªÇÐ
  • ¼ö±Þ¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå ¾î·¹ÀÌ(»ý¸í°úÇÐ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ±â±â) ½ÃÀå : À¯Çüº°(2018-2030³â)

  • DNA ¾î·¹ÀÌ
  • ´Ü¹éÁú ¾î·¹ÀÌ
  • Á¶Á÷ ¾î·¹ÀÌ
  • ¼¿ ¾î·¹ÀÌ
  • ±âŸ(ÆéƼµå ¾î·¹ÀÌ, ±âŸ)

Á¦6Àå ¾î·¹ÀÌ(»ý¸í°úÇÐ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ±â±â) ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2018-2030³â)

  • ¹ÙÀÌ¿ÀÀǾàǰ ¹× Á¦¾à±â¾÷
  • Áø´Ü ½ÇÇè½Ç
  • ¿¬±¸½Ç
  • ±âŸ(Çмú±â°ü, ±âŸ)

Á¦7Àå ¾î·¹ÀÌ(»ý¸í°úÇÐ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ±â±â) ½ÃÀå : Áö¿ªº°(2018-2030³â)

  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • ³²¹Ì
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ³²¹Ì
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ÇÁ¶û½º
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾Æ ÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • ASEAN
  • È£ÁÖ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾Æ ÅÂÆò¾ç
  • Áßµ¿
  • GCC
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï ±¸µµ

  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Roche Diagnostics Nederland BV
  • Bio-Rad Laboratories, Inc.
  • Life Technologies
  • Caliper Life Sciences
  • Perkin Elmer, Inc.
  • Siemens Healthineers
  • Agilent Technologies Inc.
  • PathogenDx, Inc.
  • Twist Bioscience Corporation
  • Arraylt Corporation
  • Molecular Device, LLC
  • Raybiotech Inc.

Á¦9Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ȸ»ç ¼Ò°³
LYJ 23.10.06

The global array market (Life Science and Biotechnology Instruments) is estimated to be valued at US$ 7.4 Billion in 2023 and is expected to exhibit a CAGR of 15.4% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 7.4 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 15.40% 2030 Value Projection: US$ 20.15 Bn
Array Market - IMG1

A DNA microarray or chip is a semiconductor surface on which sequences of many varied genes are bonded to probes. DNA microarrays are used to genotype different areas of a genome or to assess the expression levels of several genes at once. The method is applicable to areas such as clinical diagnostics, agriculture, environmental management, and other fields. A microarray or biochip is a lab-oriented microscope slide that is usually made of glass, a silicon chip, or a nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions.

Market Dynamics

Microarrays leverage biological information with bioinformatics knowledge to bring new insights to many biological systems and have been applied most intensively to the field of cancer research. A microarray, therefore, measures the levels of mRNA transcripts in a sample, and since thousands of gene fragments can be located on an array, it can provide a genome-wide view of gene expression in cancer. Thus, the increasing prevalence of cancer is expected to foster market growth over the forecast period. For instance, In February 2021, according to the report published by Globocan, a worldwide database of cancer incidence and mortality rates, 19.3 million new cancer cases were reported worldwide in 2020. Female breast cancer had surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases globally in 2020, followed by lung, colorectal, prostate, and stomach cancers.

Furthermore, According to the Centers for Disease Control and Prevention, there were 1,603,844 new cancer cases and 602,347 people who died of cancer in the U.S. in 2020

Key features of the study:

  • This report provides an in-depth analysis of the global array market (life science and biotechnology instruments) and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global array market (life science and biotechnology instruments) based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Illumina, Inc., Roche Diagnostics Nederland B.V., Bio-Rad Laboratories, Inc., Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., Twist Bioscience Corporation, Arraylt Corporation, Molecular Device, LLC and Raybiotech Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global array market (life science and biotechnology instruments)report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global array market (life science and biotechnology instruments)

Detailed Segmentation:

  • Global Array Market (Life Science and Biotechnology Instruments), By Type:
    • DNA Array
    • Protein Array
    • Tissue Array
    • Cell Array
    • Others(Peptide Array and Others)
  • Global Array Market (Life Science and Biotechnology Instruments), By End user:
    • Biopharmaceutical and Pharmaceutical Companies
    • Diagnostic Laboratories
    • Research Laboratories
    • Others (Academic Institutes and among Others)
  • Global Array Market (Life Science and Biotechnology Instruments), By Region:
    • NorthAmerica
    • U.S.
    • Canada
    • LatinAmerica
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • AsiaPacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • MiddleEast
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc.
    • Roche Diagnostics Nederland B.V.
    • Bio-Rad Laboratories, Inc.
    • Life Technologies
    • Caliper Life Sciences
    • Perkin Elmer, Inc.
    • Siemens Healthineers
    • Agilent Technologies Inc.
    • PathogenDx, Inc.
    • Twist Bioscience Corporation
    • Arraylt Corporation
    • Molecular Device, LLC
    • Raybiotech Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By End user
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • Technological Advancements
  • Manufacturer Revenue

4. Global Array Market (Life Science and Biotechnology Instruments) - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Array Market (Life Science and Biotechnology Instruments), By Type, 2018 - 2030,(US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • DNA Array
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Protein Array
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Tissue Array
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Cell Array
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends
  • Others (Peptide Array and among Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
    • Segment Trends

6. Global Array Market (Life Science and Biotechnology Instruments), By End user, 2018 - 2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Biopharmaceutical and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
  • Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)
  • Others (Academic Institutes and among Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Billion)

7. Global Array Market (Life Science and Biotechnology Instruments), By Region, 2018 - 2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2018 - 2030, (US$ Billion)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Illumina, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Roche Diagnostics Nederland B.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Life Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Caliper Life Sciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Perkin Elmer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Agilent Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • PathogenDx, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Twist Bioscience Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Arraylt Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Molecular Device, LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Raybiotech Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦